Study of Chandanadi Churna And Chandanadi Taila Matrabasti In The Management Of Asrigdara With Special Reference To Abnormal Uterine Bleeding

Efficacy Of Chandanadi Churna And Chandanadi Taila Matrabasti In The Management Of Asrigdara With Special Reference To Abnormal Uterine Bleeding - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/087334

Enrollment

Registered

2025-05-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified Health Condition 2: N939- Abnormal uterine and vaginal bleeding, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age group from menarche to menopause Having abnormal uterine bleeding considering duration and quantity of bleeding during menstrual Cycle

Exclusion criteria

Exclusion criteria: Organic involvement including malignancy Bleeding disorders Hb less than 8 gm/dl Patient having bleedafter menopause

Design outcomes

Primary

Measure	Time frame
decrease in the symptoms like 1.raja srava pramana(amount of bleeding) 2.raja srava kala(duration of bleeding) 3.anaritu kal(intermenstrual period)Timepoint: 15 days	—

Secondary

Measure	Time frame
Marked improvement has noticed in amount, duration and interval of menstrual bleeding including associated symptoms like vedana(pain during menstruation) and angamarda(bodyacheTimepoint: 3 months	—

Countries

India

Contacts

Public ContactDr Kaushalya Khakhlary

Govt. Ayurvedic college & Hospital,Jalukbari,Guwahati,Assam,781014

drkaushalya01@gmail.com8638787369

Outcome results